EC Requests Scientific Advice from SCCS on the Safety of Nanomaterials in Cosmetics

Bergeson & Campbell, P.C.
Contact

Bergeson & Campbell, P.C.

The Scientific Committee on Consumer Safety (SCCS) announced on February 6, 2020, that the European Commission (EC) has requested scientific advice on the safety of nanomaterials in cosmetics.  The EC seeks advices on two questions:

  • The EC requests that SCCS determine the nanomaterials, as published in the recent catalogue of nanomaterials of 2019, for which specific concerns can be identified and justified to establish a priority list of nanomaterials for risk assessment (Article 16(4) Reg.1223/2009). The EC asks that SCCS provide a description of the specific concerns that have been identified.  According to the request, this process should be based on the currently available scientific literature and SCCS’s expert judgment.
  • For the nanomaterials with inconclusive SCCS opinions, the EC requests that SCCS assess if a potential risk can be identified according to Article 16(6) Reg.1223/2009. Such assessment, regardless of the data previously submitted by the respective applicants, should be based on the available scientific literature and SCCS’s expert judgment (i.e., systemic or local availability; harmful effects specifically related to nanoform; surface catalyzed reactions in nanoform, absorption (or potential absorption) from dermal and inhalation routes, or potential of nanoform to deliver ionic forms).  The inconclusive SCCS opinions specified in the request include Colloidal Silver (nano) (SCCS/1596/18), Styrene/Acrylates copolymer (nano) + Sodium styrene/Acrylates copolymer (nano) (SCCS/1595/18), and Silica, Hydrated Silica, and Silica Surface Modified with Alkyl Silylates (nanoform) (SCCS/1545/15).

To avoid conflicting opinions with other bodies, the EC invites SCCS to consult the Scientific Committee on Health, Environmental and Emerging Risks (SCHEER).

[View source.]

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Bergeson & Campbell, P.C. | Attorney Advertising

Written by:

Bergeson & Campbell, P.C.
Contact
more
less

Bergeson & Campbell, P.C. on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.